| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |